RegisterLogin

Linaclotide

CAT: 0804-HY-17584-01Size: 5 mgDry Ice: NoHazardous: No
HY-17584-015 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Linaclotide is a potent and selective guanylate cyclase C agonist; developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation.
CAS Number
[851199-59-2]
UNSPSC
12352209
Hazard Statement
H302
Target
Guanylate Cyclase
Type
Reference compound
Related Pathways
GPCR/G Protein
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Linaclotide.html
Purity
99.77
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : 16.67 mg/mL (ultrasonic; adjust pH to 2 with HCl)
Smiles
O=C([C@@H](NC([C@@](CSSC[C@@H]1N)([H])NC([C@@](CSSC[C@H](N2)C(N[C@H](C(O)=O)CC3=CC=C(O)C=C3)=O)([H])NC([C@@H](NC([C@@H](N4)CCC(O)=O)=O)CC5=CC=C(O)C=C5)=O)=O)=O)CC(N)=O)N6[C@@](C(N[C@H](C(N[C@](CSSC[C@](C4=O)([H])NC1=O)([H])C(NC(C(NCC2=O)=O)[C@H](O)C)=O)=O)C)=O)([H])CCC6
Molecular Formula
C59H79N15O21S6
Molecular Weight
1526.74
Precautions
H302
References & Citations
[1]Bryant AP, et al. Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract. Life Sci. 2010 May 8;86 (19-20) :760-5.|[2]Love BL, et al. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome. Am J Health Syst Pharm. 2014 Jul 1;71 (13) :1081-91.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched

Related Products

CatalogName

Alternative Products

CatalogName
BA5387-5Linaclotide
BA5387-100Linaclotide
BUP05450-01Linaclotide
C06861Linaclotide
M16183-01Linaclotide
BA5387-10Linaclotide
MBS5753413Linaclotide
MBS3606180-01Linaclotide
MBS385522-01Linaclotide
164757-01Linaclotide

Popular Products